Comparison of Efficacy and Safety of Vildagliptin and Linagliptin in Patients of Type 2 Diabetes Mellitus with Chronic Kidney Disease. Comm. Based Med J. 2025;14(1):96-100. doi:10.3329/cbmj.v14i1.79340